Embyonic stem cells

The FDA has approved a study which will inject embyonic stem cells into humans.

The Geron corporation announce the approval today. The therapy used in the study is designed to treat spinal cord injuries by injecting stem cells — which are able to transform into the many different types of cells we need in our bodies — directly into the patients’ spinal cords.

The U.S. Food and Drug Administration (FDA) granted clearance of the company’s application for the clinical trial of GRNOPC1 in patients with acute spinal cord injury.

“This marks the beginning of what is potentially a new chapter in medical therapeutics – one that reaches beyond pills to a new level of healing: the restoration of organ and tissue function achieved by the injection of healthy replacement cells,” said Geron’s president and CEO. Dr. Thomas B. Okarma.

“The neurosurgical community is very excited by this new approach to treating devastating spinal cord injury,” said Dr. Richard Fessler, a professor of neurological surgery at the Feinberg School of Medicine at Northwestern University.

While, according to the article this doesn’t have much to do with the recent shift from hating science and its beauty to embracing truth (the shift from Bush to Obama), it is pretty exciting. Stem cells are wonderful things. If some major theraputic treatment does not arise out of these cells, I’ll be awfully surprised (and the scientific community). I think it may be safe enough to say if many treatments do not come from stem cells, the surprise will be huge around the world. These far-from-conscious cells are the future of medical science.

Leave a comment

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: